協和キリンの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2025/04/17 | 2,187.5 | 2,194 | 2,162 | 2,194 | -9 | -0.4% | 1,487,300 |
2025/04/16 | 2,172 | 2,209 | 2,152 | 2,203 | +35 | +1.6% | 1,144,100 |
2025/04/15 | 2,170 | 2,178 | 2,153.5 | 2,168 | +19.5 | +0.9% | 917,100 |
2025/04/14 | 2,118 | 2,175.5 | 2,118 | 2,148.5 | +63.5 | +3% | 1,295,500 |
2025/04/11 | 2,071 | 2,105 | 2,034 | 2,085 | -36 | -1.7% | 1,865,600 |
2025/04/10 | 2,142.5 | 2,144 | 2,067 | 2,121 | +68.5 | +3.3% | 1,420,300 |
2025/04/09 | 2,079.5 | 2,094 | 2,037 | 2,052.5 | -23.5 | -1.1% | 1,594,200 |
2025/04/08 | 2,106.5 | 2,107 | 2,050 | 2,076 | +3 | +0.1% | 1,325,500 |
2025/04/07 | 2,076.5 | 2,119.5 | 2,037.5 | 2,073 | -131 | -5.9% | 1,785,800 |
2025/04/04 | 2,121.5 | 2,223 | 2,121.5 | 2,204 | +84.5 | +4% | 1,915,800 |
2025/04/03 | 2,111 | 2,127.5 | 2,100.5 | 2,119.5 | -10 | -0.5% | 1,177,300 |
2025/04/02 | 2,191 | 2,205 | 2,127 | 2,129.5 | -34 | -1.6% | 1,126,600 |
2025/04/01 | 2,166.5 | 2,181.5 | 2,144.5 | 2,163.5 | -9.5 | -0.4% | 1,363,600 |
2025/03/31 | 2,178 | 2,192.5 | 2,150.5 | 2,173 | -31.5 | -1.4% | 1,454,700 |
2025/03/28 | 2,212 | 2,212 | 2,190 | 2,204.5 | +0.5 | ±0% | 824,600 |
2025/03/27 | 2,194.5 | 2,204 | 2,180 | 2,204 | +33.5 | +1.5% | 1,242,200 |
2025/03/26 | 2,167.5 | 2,186.5 | 2,162 | 2,170.5 | -5 | -0.2% | 1,003,400 |
2025/03/25 | 2,150 | 2,181.5 | 2,148 | 2,175.5 | +25.5 | +1.2% | 709,700 |
2025/03/24 | 2,150 | 2,168.5 | 2,138 | 2,150 | +11.5 | +0.5% | 655,400 |
2025/03/21 | 2,158.5 | 2,161 | 2,136 | 2,138.5 | -39 | -1.8% | 1,898,200 |
2025/03/19 | 2,169 | 2,187.5 | 2,167 | 2,177.5 | -6.5 | -0.3% | 859,900 |
2025/03/18 | 2,182 | 2,190 | 2,166.5 | 2,184 | +5 | +0.2% | 959,900 |
2025/03/17 | 2,161.5 | 2,197.5 | 2,155.5 | 2,179 | +1 | ±0% | 622,600 |
2025/03/14 | 2,153.5 | 2,183 | 2,130 | 2,178 | -1 | ±0% | 1,844,300 |
2025/03/13 | 2,189 | 2,201 | 2,159 | 2,179 | -22 | -1% | 2,044,900 |
2025/03/12 | 2,202 | 2,221.5 | 2,183 | 2,201 | -22.5 | -1% | 1,788,700 |
2025/03/11 | 2,243.5 | 2,261.5 | 2,213.5 | 2,223.5 | -24.5 | -1.1% | 1,523,300 |
2025/03/10 | 2,250 | 2,288 | 2,233.5 | 2,248 | +25.5 | +1.1% | 1,967,900 |
2025/03/07 | 2,188 | 2,234 | 2,179.5 | 2,222.5 | +56 | +2.6% | 1,662,200 |
2025/03/06 | 2,160 | 2,169 | 2,143 | 2,166.5 | -12.5 | -0.6% | 1,255,200 |
2025/03/05 | 2,175.5 | 2,213 | 2,169.5 | 2,179 | +10 | +0.5% | 1,299,000 |
2025/03/04 | 2,160 | 2,177.5 | 2,144 | 2,169 | +18.5 | +0.9% | 1,190,700 |
2025/03/03 | 2,154 | 2,165 | 2,129 | 2,150.5 | +31 | +1.5% | 888,800 |
2025/02/28 | 2,125 | 2,148.5 | 2,108.5 | 2,119.5 | -17.5 | -0.8% | 1,794,100 |
2025/02/27 | 2,122.5 | 2,148.5 | 2,117 | 2,137 | +29 | +1.4% | 1,205,000 |
2025/02/26 | 2,110 | 2,118.5 | 2,093 | 2,108 | +19.5 | +0.9% | 1,337,100 |
2025/02/25 | 2,055 | 2,090 | 2,046 | 2,088.5 | +24.5 | +1.2% | 1,501,300 |
2025/02/21 | 2,062.5 | 2,083.5 | 2,055.5 | 2,064 | +26.5 | +1.3% | 1,358,200 |
2025/02/20 | 2,049 | 2,051.5 | 2,025 | 2,037.5 | +1 | ±0% | 965,100 |
2025/02/19 | 2,034 | 2,049.5 | 2,031 | 2,036.5 | -21 | -1% | 990,200 |
2025/02/18 | 2,045 | 2,074.5 | 2,038.5 | 2,057.5 | +4 | +0.2% | 863,300 |
2025/02/17 | 2,051 | 2,079.5 | 2,048 | 2,053.5 | -12.5 | -0.6% | 723,900 |
2025/02/14 | 2,093 | 2,105 | 2,056.5 | 2,066 | -40.5 | -1.9% | 1,335,400 |
2025/02/13 | 2,093 | 2,133 | 2,090 | 2,106.5 | +36.5 | +1.8% | 1,305,100 |
2025/02/12 | 2,076 | 2,080 | 2,045 | 2,070 | -8.5 | -0.4% | 1,706,400 |
2025/02/10 | 2,098.5 | 2,110 | 2,062.5 | 2,078.5 | -38.5 | -1.8% | 2,093,500 |
2025/02/07 | 2,135 | 2,142.5 | 2,090 | 2,117 | -123 | -5.5% | 2,813,000 |
2025/02/06 | 2,269.5 | 2,277.5 | 2,223 | 2,240 | -14 | -0.6% | 908,800 |
2025/02/05 | 2,257.5 | 2,257.5 | 2,226.5 | 2,254 | +13.5 | +0.6% | 843,500 |
2025/02/04 | 2,277 | 2,281 | 2,230.5 | 2,240.5 | +11 | +0.5% | 692,400 |
51~
100
件表示中 / 3732件
類似銘柄と比較する
現在ご覧いただいている「協和キリン」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
協和キリン | 243,700円 | -3.5% | -11.3% | 2.46% | 22.38倍 | 1.52倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
アステラス薬 | 139,100円 | +0.9% | +380.2% | 5.61% | 19.16倍 | 1.68倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
塩野義 | 254,800円 | +20.9% | +10.6% | 2.59% | 12.04倍 | 1.62倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
エーザイ | 407,300円 | +0.1% | -3.4% | 3.93% | 27.69倍 | 1.39倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
小野薬 | 153,900円 | +0.6% | +43.3% | 5.20% | 10.79倍 | 0.94倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム